Search results for "interleukin-6"

showing 10 items of 370 documents

Cutting Edge: IL-6–Driven Immune Dysregulation Is Strictly Dependent on IL-6R α-Chain Expression

2020

Abstract IL-6 binds to the IL-6R α-chain (IL-6Rα) and signals via the signal transducer gp130. Recently, IL-6 was found to also bind to the cell surface glycoprotein CD5, which would then engage gp130 in the absence of IL-6Rα. However, the biological relevance of this alternative pathway is under debate. In this study, we developed a mouse model, in which murine IL-6 is overexpressed in a CD11c-Cre–dependent manner. Transgenic mice developed a lethal immune dysregulation syndrome with increased numbers of Ly-6G+ neutrophils and Ly-6Chi monocytes/macrophages. IL-6 overexpression promoted activation of CD4+ T cells while suppressing CD5+ B-1a cell development. However, additional ablation of …

Genetically modified mouseImmunologyInflammationMice Transgenicmedicine.disease_cause03 medical and health sciencesMice0302 clinical medicineRare DiseasesmedicineImmunology and AllergyAnimals2.1 Biological and endogenous factorsInflammatory and Immune SystemReceptorSTAT3biologyCell growthChemistryInterleukin-6Immune dysregulationGlycoprotein 130Receptors Interleukin-6Cell biologybiology.proteinAlternative complement pathwaymedicine.symptom030215 immunologySignal TransductionThe Journal of Immunology
researchProduct

TGF-β Suppresses Tumor Progression in Colon Cancer by Inhibition of IL-6 trans-Signaling

2004

Alterations of TGF-beta signaling have been described in colorectal cancer, although the molecular consequences are largely unknown. By using transgenic mice overexpressing TGF-beta or a dominant-negative TGF-betaRII, we demonstrate that TGF-beta signaling in tumor infiltrating T lymphocytes controls the growth of dysplastic epithelial cells in experimental colorectal cancer, as determined by histology and a novel system for high-resolution chromoendoscopy. At the molecular level, TGF-beta signaling in T cells regulated STAT-3 activation in tumor cells via IL-6. IL-6 signaling required tumor cell-derived soluble IL-6R rather than membrane bound IL-6R and suppression of such TGF-beta-depende…

Genetically modified mouseSTAT3 Transcription FactorColorectal cancerRecombinant Fusion ProteinsT-LymphocytesImmunologyBlotting WesternEnzyme-Linked Immunosorbent AssayMice TransgenicProtein Serine-Threonine KinasesMiceIn vivoTransforming Growth Factor betamedicineImmunology and AllergyAnimalsHumansEndoscopy Digestive SystemIntestinal MucosaInterleukin 6Autocrine signallingMice KnockoutbiologyInterleukin-6Reverse Transcriptase Polymerase Chain ReactionReceptor Transforming Growth Factor-beta Type IIHistologymedicine.diseaseImmunohistochemistryReceptors Interleukin-6DNA-Binding ProteinsDisease Models AnimalInfectious DiseasesTumor progressionImmunologyColonic NeoplasmsCancer researchbiology.proteinDisease ProgressionTrans-ActivatorsReceptors Transforming Growth Factor betaTransforming growth factorSignal TransductionImmunity
researchProduct

The function of the soluble IL-6 receptor in vivo.

1996

Interleukin-6 (IL-6) is considered an important mediator of acute inflammatory responses. Moreover, IL-6 functions as a differentiation and growth factor of hematopoietic precursor cells, B-cells, T-cells, keratinocytes, neuronal cells, osteoclasts and endothelial cells. IL-6 exhibits its action via a receptor complex consisting of a specific IL-6 receptor (IL-6R) and a signal-transducing subunit (gp130). Soluble forms of both receptor components are generated by shedding and are found in patients with various diseases such as AIDS, rheumatoid arthritis and others. The function of the soluble IL-6R in vivo is unknown. To discriminate between the biologic function of hIL-6 alone and that of …

Genetically modified mousemedicine.medical_specialtyReceptor complexTransgenemedicine.medical_treatmentImmunologyMice TransgenicBiologyMiceAntigens CDInternal medicinemedicineHypersensitivityImmunology and AllergyAnimalsHumansReceptorInterleukin-6Growth factorReceptors InterleukinGlycoprotein 130Hematopoietic Stem CellsReceptors Interleukin-6Cell biologyHaematopoiesisEndocrinologySolubilityInterleukin-6 receptorCarrier ProteinsAcute-Phase ProteinsImmunology letters
researchProduct

Inflammation and frailty in the elderly: A systematic review and meta-analysis

2016

The pathogenesis of frailty and the role of inflammation is poorly understood. We examined the evidence considering the relationship between inflammation and frailty through a systematic review and meta-analysis. A systematic literature search of papers providing data on inflammatory biomarkers and frailty was carried out in major electronic databases from inception until May 2016. From 1856 initial hits, 35 studies (32 cross-sectional studies n = 3232 frail, n = 11,483 pre-frail and n = 8522 robust, and 563 pre-frail + robust; 3 longitudinal studies n = 3402 participants without frailty at baseline) were meta-analyzed. Cross-sectional studies reported that compared to 6757 robust participa…

GerontologyMalemedicine.medical_specialtyAgingNeurologyFrail ElderlyInflammationPre-frailtyBiochemistry03 medical and health sciencesFibrinogen levels0302 clinical medicineInternal medicineWhite blood cellmedicine80 and overHumans030212 general & internal medicineMolecular BiologyAgedAged 80 and overInflammationbiologyInflammation Pre-frailty Frailty Aging C-Reactive proteFrailtybusiness.industryInterleukin-6C-reactive proteinC-Reactive proteinInflammatory biomarkersAgeingmedicine.anatomical_structureAging; C-Reactive protein; Frailty; Inflammation; Interleukin-6; Pre-frailty; Aged; Aged 80 and over; Biomarkers; Cytokines; Female; Humans; Inflammation; Male; Frail ElderlyNeurologyMeta-analysisbiology.proteinCytokinesFemalemedicine.symptombusiness030217 neurology & neurosurgeryBiomarkersSystematic searchBiotechnologyAging; C-Reactive protein; Frailty; Inflammation; Interleukin-6; Pre-frailty
researchProduct

A role for the immunoglobulin-like domain of the human IL-6 receptor. Intracellular protein transport and shedding.

1999

Interleukin (IL)-6, IL-11 and cililary neurotrophic factor (CNTF) belong to the same family of hematopoietic and neurotrophic cytokines. Their receptor complexes contain a cytokine-binding alpha receptor and the common glycoprotein (gp)130 subunit for signal transduction. The extracellular parts of the alpha-receptor subunits consist of a membrane-proximal cytokine-binding domain and an N-terminal immunoglobulin (Ig)-like domain with unknown function. We examined the role of the Ig-like domain of IL-6R by constructing deletion mutants lacking the Ig domain (IL-6RDeltaIg and soluble IL-6RDeltaIg). IL-6RDeltaIg was shed as effectively as wild-type IL-6R from transfected COS-7 cells upon 4beta…

GlycosylationTime FactorsImmunoglobulin domainBiologyTransfectionBiochemistryModels BiologicalCell LineMiceAnimalsHumansSecretionSecretory pathwayMembrane GlycoproteinsDose-Response Relationship DrugInterleukin-6Lysosome-Associated Membrane GlycoproteinsTransfectionGlycoprotein 130Flow CytometryMolecular biologyReceptors Interleukin-6Transmembrane proteinRecombinant ProteinsCell biologyInterleukin-6 receptorCOS CellsTetradecanoylphorbol AcetateSignal transductionSignal TransductionEuropean journal of biochemistry
researchProduct

The designer cytokine hyper-IL-6 mediates growth inhibition and GM-CSF-dependent rejection of B16 melanoma cells.

2000

The low immunogenic B16 melanoma cell line was transfected with a mammalian expression vector containing the complementary DNA for a sIL-6R/IL-6 fusion protein, termed Hyper-IL-6 (H-IL-6), which was shown to have biological activities at 100-1000-fold lower concentrations than IL-6 in combination with sIL-6R. The secreted p84 glycoprotein was detected in the supernatant of transfected cells and was fully active on BAF3/gp130 cells, which respond to IL-6/sIL-6R but not to IL-6 alone. Administration of recombinant H-IL-6 to C57BL/6 mice resulted in a prolonged acute phase protein gene expression indicating long systemic persistence of the fusion protein. Transfected B16 cells (B16/H-IL6 cells…

Graft RejectionCancer ResearchTumor suppressor geneRatónmedicine.medical_treatmentRecombinant Fusion ProteinsMelanoma ExperimentalMice TransgenicTransfectionchemistry.chemical_compoundMiceGene expressionGeneticsmedicineAnimalsDrug InteractionsInterleukin 6neoplasmsMolecular BiologybiologyInterleukin-6MelanomaGranulocyte-Macrophage Colony-Stimulating FactorReceptors Interleukinmedicine.diseaseReceptors Interleukin-6Growth Inhibitorsrespiratory tract diseasesCytokinechemistryCell cultureReceptors Granulocyte-Macrophage Colony-Stimulating FactorImmunologybiology.proteinCancer researchGrowth inhibitionImmunosuppressive AgentsOncogene
researchProduct

Possible role of human interleukin-6 and soluble interleukin-6 receptor in hepatitis B virus infection

2001

Human interleukin-6 has been shown to promote hepatitis B virus (HBV) infection. However, it is not clear whether this influence is the result of a direct interaction between interleukin-6 (IL-6) and the HBV envelope proteins or of a rather indirect mechanism. A direct interaction of IL-6 and the preS region of the large envelope protein (L-protein) of HBV has been reported. In this study we assessed the binding of IL-6 and of the IL-6 receptor subunits to the preS region of the L-protein of HBV. Binding of IL-6 and IL-6 receptor subunits sIL-6R and gp130 to preS was assessed by immunoprecipitation with recombinant preS proteins. In patient sera IL-6 and sIL-6R concentrations were analysed …

Hepatitis B virusmedicine.disease_causeHepatitis B virus PRE betalaw.inventionHepatitis B ChroniclawVirologyEscherichia colimedicineAnimalsHumansProtein PrecursorsInterleukin 6ReceptorCells CulturedHepatitis B virusHepatitis B Surface AntigensHepatologybiologyInterleukin-6Chemistryvirus diseasesViral LoadHepatitis BGlycoprotein 130medicine.diseasePrecipitin TestsReceptors Interleukin-6VirologyMolecular biologyRecombinant ProteinsInfectious DiseasesSolubilityCOS CellsRecombinant DNAbiology.proteinViral loadCell DivisionPlasmidsJournal of Viral Hepatitis
researchProduct

In vitro production of anti-neutrophilocyte-cytoplasm-antibodies (ANCA) by Epstein-Barr virus-transformed B-cell lines in Wegener's granulomatosis.

1991

The frequent detection of anti-neutrophilocyte-cytoplasm-antibodies (ANCA) in patients with Wegener's granulomatosis (WG) led to the supposition that this disease might be of autoimmune nature. For some authors assume that Epstein-Barr virus (EBV) infection of human B-lymphocytes besides polyclonal activation could reveal the cryptic immune status against different autoantigens in patients with autoimmune diseases we investigated EBV-transformed B-lymphocytes from patients with Sjögren's syndrome, mixed connective tissue disease, WG and healthy blood donors. Two stable B-cell lines (Ho3, We1) could be established. Inhibition experiments showed that antibodies produced by transformed B-lymph…

Herpesvirus 4 HumanImmunologyBlotting WesternKidney GlomerulusFluorescent Antibody TechniqueCross ReactionsIn Vitro Techniquesmedicine.disease_causeVirusAntibodies Antineutrophil CytoplasmicMixed connective tissue diseaseAntigenmedicineImmunology and AllergyHumansB cellAgedAutoantibodiesB-LymphocytesbiologyInterleukin-6Granulomatosis with PolyangiitisMiddle Agedmedicine.diseaseCell Transformation ViralEpstein–Barr virusVirologymedicine.anatomical_structureImmunoglobulin MPolyclonal antibodiesImmunoglobulin GImmunologybiology.proteinKeratinsAntibodyClone (B-cell biology)Autoimmunity
researchProduct

Blocking Activin Receptor Ligands Is Not Sufficient to Rescue Cancer-Associated Gut Microbiota—A Role for Gut Microbial Flagellin in Colorectal Cance…

2019

Colorectal cancer (CRC) and cachexia are associated with the gut microbiota and microbial surface molecules. We characterized the CRC-associated microbiota and investigated whether cachexia affects the microbiota composition. Further, we examined the possible relationship between the microbial surface molecule flagellin and CRC. CRC cells (C26) were inoculated into mice. Activin receptor (ACVR) ligands were blocked, either before tumor formation or before and after, to increase muscle mass and prevent muscle loss. The effects of flagellin on C26-cells were studied in vitro. The occurrence of similar phenomena were studied in murine and human tumors. Cancer modulated the gut microbiota witho…

INTERLEUKIN-6suolistomikrobisto3122 CancersmicrobiomeENTEROCOCCUS-FAECALISlcsh:RC254-282ArticlePATHWAYACTIVATIONMOUSE MODELSIL-6 EXPRESSIONpaksusuolisyöpätulehdusCOLON-CANCERactivinliganditlcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogensIL6inflammationmyostatinSKELETAL-MUSCLEproteiinitlihassurkastumasairaudetTUMOR MICROENVIRONMENTCCL2MCP-1Cancers
researchProduct

Mast cells enhance proliferation of B lymphocytes and drive their differentiation toward IgA-secreting plasma cells.

2010

AbstractThe evidence of a tight spatial interaction between mast cells (MCs) and B lymphocytes in secondary lymphoid organs, along with the data regarding the abundance of MCs in several B-cell lymphoproliferative disorders prompted us to investigate whether MCs could affect the proliferation and differentiation of B cells. To this aim, we performed coculture assays using mouse splenic B cells and bone marrow–derived MCs. Both nonsensitized and activated MCs proved able to induce a significant inhibition of cell death and an increase in proliferation of naive B cells. Such proliferation was further enhanced in activated B cells. This effect relied on cell-cell contact and MC-derived interle…

Immunoglobulin AMAST CELL B LYMPHOCITESCellular differentiationImmunologyNaive B cellCD40 LigandPlasma CellsCell CommunicationImmunoglobulin ELymphocyte ActivationBiochemistryMast cellMiceImmune systemIg isotype switchmedicineAnimalsHumansMast CellsCD40 AntigensCell ProliferationIG-A.B cellB cellsMast cell; B cells; Differentiation; Ig isotype switchCD40biologyCell DeathInterleukin-6Cell DifferentiationCell BiologyHematologyMast cellhumanitiesCell biologyImmunity HumoralImmunoglobulin Amedicine.anatomical_structureGene Expression RegulationDifferentiationImmunologybiology.proteinMAST CELL B LYMPHOCITES; IG-A.Syndecan-1AntibodyBlood
researchProduct